Access the full text.
Sign up today, get DeepDyve free for 14 days.
C. Meisenberg, S. Ward, P. Schmid, Sherif El-khamisy (2014)
TDP1/TOP1 Ratio as a Promising Indicator for the Response of Small Cell Lung Cancer to TopotecanJournal of cancer science & therapy, 6
Ram Seshadri (2004)
Crystal structures
(2021)
MCF7 breast cancer cells selected for tamoxifen resistance acquire new phenotypes
Abdullahi Ibrahim, Mehmet Özsöz, Zubaid Saeed, Galaya Tirah, Ojo Gideon (2019)
Genome Engineering Using the CRISPR Cas9 System
M. Eldridge, C. Murray, T. Auton, G. Paolini, R. Mee (1997)
Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexesJournal of Computer-Aided Molecular Design, 11
(2000)
The protein data bankNucleic Acids Res, 28
(2010)
Integration, scaling, space-group assignment and post-refinementActa Crystallogr D Biol Crystallogr, 66
Joyce Hung, H. Arabshahi, E. Leung, J. Reynisson, D. Barker (2014)
Synthesis and cytotoxicity of thieno[2,3-b]pyridine and furo[2,3-b]pyridine derivatives.European journal of medicinal chemistry, 86
N. Li-Zhulanov, A. Zakharenko, A. Chepanova, Jinal Patel, A. Zafar, K. Volcho, N. Salakhutdinov, J. Reynisson, Ivanhoe Leung, O. Lavrik (2018)
A Novel Class of Tyrosyl-DNA Phosphodiesterase 1 Inhibitors That Contains the Octahydro-2H-chromen-4-ol ScaffoldMolecules : A Journal of Synthetic Chemistry and Natural Product Chemistry, 23
E. Leung, J. Kim, Marjan Askarian-Amiri, G. Rewcastle, G. Finlay, B. Baguley (2014)
Relationships between Signaling Pathway Usage and Sensitivity to a Pathway Inhibitor: Examination of Trametinib Responses in Cultured Breast Cancer LinesPLoS ONE, 9
Leroy Liu, S. Desai, Tsai-Kun Li, Y. Mao, Mei Sun, S. Sim (1996)
Mechanism of Action of CamptothecinAnnals of the New York Academy of Sciences, 922
A. Zafar, L. Pilkington, Natalie Haverkate, M. Rensburg, E. Leung, Sisira Kumara, W. Denny, D. Barker, Ali Alsuraifi, Clare Hoskins, J. Reynisson (2018)
Investigation into Improving the Aqueous Solubility of the Thieno[2,3-b]pyridine Anti-Proliferative AgentsMolecules : A Journal of Synthetic Chemistry and Natural Product Chemistry, 23
S. Walker, C. Meisenberg, R. Bibby, Trevor Askwith, Gareth Williams, F. Rininsland, L. Pearl, A. Oliver, Sherif El-khamisy, S. Ward, J. Atack (2014)
Development of an oligonucleotide-based fluorescence assay for the identification of tyrosyl-DNA phosphodiesterase 1 (TDP1) inhibitorsAnalytical Biochemistry, 454
A. Zakharenko, T. Khomenko, S. Zhukova, O. Koval, O. Zakharova, R. Anarbaev, N. Lebedeva, D. Korchagina, N. Komarova, V. Vasiliev, J. Reynisson, K. Volcho, N. Salakhutdinov, O. Lavrik (2015)
Synthesis and biological evaluation of novel tyrosyl-DNA phosphodiesterase 1 inhibitors with a benzopentathiepine moiety.Bioorganic & medicinal chemistry, 23 9
Z. Taira, H. Terada (1985)
Specific and non-specific ligand binding to serum albumin.Biochemical pharmacology, 34 11
J. Murai, Shar-yin Huang, B. Das, T. Dexheimer, S. Takeda, Y. Pommier (2012)
Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Repairs DNA Damage Induced by Topoisomerases I and II and Base Alkylation in Vertebrate Cells*The Journal of Biological Chemistry, 287
H. Berman, K. Henrick, Haruki Nakamura (2003)
Announcing the worldwide Protein Data BankNature Structural Biology, 10
A. Mastelić, Vedrana Čulić, Nikolina Mužinić, Milena Vuica-Ross, D. Barker, E. Leung, J. Reynisson, A. Markotić (2017)
Glycophenotype of breast and prostate cancer stem cells treated with thieno[2,3-b]pyridine anticancer compoundDrug Design, Development and Therapy, 11
E. Leung, Nagarajan Kannan, G. Krissansen, M. Findlay, B. Baguley (2010)
MCF-7 breast cancer cells selected for tamoxifen resistance acquire new phenotypes differing in DNA content, phospho-HER2 and PAX2 expression, and rapamycin sensitivityCancer Biology & Therapy, 9
E. Mozhaitsev, E. Suslov, Yuliya Demidova, D. Korchagina, K. Volcho, A. Zakharenko, I. Vasil’eva, Maksim Kupryushkin, A. Chepanova, D. Ayine-Tora, J. Reynisson, N. Salakhutdinov, O. Lavrik (2019)
The Development of Tyrosyl-DNA Phosphodyesterase 1 (TDP1) Inhibitors Based on the Amines Combining Aromatic/Heteroaromatic and Monoterpenoid MoietiesLetters in Drug Design & Discovery
Chunyan Liu, Jeffrey Pouliot, H. Nash (2002)
Repair of topoisomerase I covalent complexes in the absence of the tyrosyl-DNA phosphodiesterase Tdp1Proceedings of the National Academy of Sciences of the United States of America, 99
E. Leung, Joyce Hung, D. Barker, J. Reynisson (2014)
The effect of a thieno[2,3- b ]pyridine PLC-γ inhibitor on the proliferation, morphology, migration and cell cycle of breast cancer cellsMedChemComm, 5
M. Rensburg, E. Leung, Natalie Haverkate, Chatchakorn Eurtivong, L. Pilkington, J. Reynisson, D. Barker (2017)
Synthesis and antiproliferative activity of 2-chlorophenyl carboxamide thienopyridines.Bioorganic & medicinal chemistry letters, 27 2
H. Arabshahi, E. Leung, D. Barker, J. Reynisson (2014)
The development of thieno[2,3-b]pyridine analogues as anticancer agents applying in silico methodsMedChemComm, 5
Ann-Katrine Jakobsen, K. Lauridsen, Evelyn Samuel, Joanna Proszek, B. Knudsen, H. Hager, M. Stougaard (2015)
Correlation between topoisomerase I and tyrosyl-DNA phosphodiesterase 1 activities in non-small cell lung cancer tissue.Experimental and molecular pathology, 99 1
(2021)
evidence for binding to an enzymeDNA complex
(Scigress Ultra V, F.J 2.6. (EU 3.1.7); Fujitsu Limited: 2008–2016.)
Scigress Ultra V, F.J 2.6. (EU 3.1.7); Fujitsu Limited: 2008–2016.Scigress Ultra V, F.J 2.6. (EU 3.1.7); Fujitsu Limited: 2008–2016., Scigress Ultra V, F.J 2.6. (EU 3.1.7); Fujitsu Limited: 2008–2016.
Z. Zeng, A. Sharma, Limei Ju, J. Murai, L. Umans, L. Vermeire, Y. Pommier, S. Takeda, D. Huylebroeck, K. Caldecott, Sherif El-khamisy (2012)
TDP2 promotes repair of topoisomerase I-mediated DNA damage in the absence of TDP1Nucleic Acids Research, 40
M. Berenbaum (1981)
Criteria for analyzing interactions between biologically active agents.Advances in cancer research, 35
E. Leung, L. Pilkington, M. Rensburg, Chae Jeon, Mirae Song, H. Arabshahi, G. Zoysa, V. Sarojini, W. Denny, J. Reynisson, D. Barker (2016)
Synthesis and cytotoxicity of thieno[2,3-b]quinoline-2-carboxamide and cycloalkyl[b]thieno[3,2-e]pyridine-2-carboxamide derivatives.Bioorganic & medicinal chemistry, 24 5
D. Davies, H. Interthal, J. Champoux, W. Hol (2002)
The crystal structure of human tyrosyl-DNA phosphodiesterase, Tdp1.Structure, 10 2
D. Michod, C. Widmann (2007)
DNA-damage sensitizers: potential new therapeutical tools to improve chemotherapy.Critical reviews in oncology/hematology, 63 2
H. Berman, Tammy Battistuz, T. Bhat, Wolfgang Bluhm, Philip Bourne, K. Burkhardt, Zukang Feng, G. Gilliland, L. Iype, Shri Jain, Phoebe Fagan, Jessica Marvin, David Padilla, V. Ravichandran, B. Schneider, N. Thanki, H. Weissig, J. Westbrook, C. Zardecki
Electronic Reprint Biological Crystallography the Protein Data Bank Biological Crystallography the Protein Data Bank
W. Kabsch (2006)
Integration, scaling, space‐group assignment and post refinementInternational Tables for Crystallography
O. Salomatina, I. Popadyuk, A. Zakharenko, O. Zakharova, A. Chepanova, N. Dyrkheeva, N. Komarova, J. Reynisson, R. Anarbaev, N. Salakhutdinov, O. Lavrik, K. Volcho (2020)
Deoxycholic acid as a molecular scaffold for tyrosyl-DNA phosphodiesterase 1 inhibition: A synthesis, structure–activity relationship and molecular modeling studySteroids, 165
R. Chaudhari, Zhijun Li (2015)
PyMine: a PyMOL plugin to integrate and visualize data for drug discoveryBMC Research Notes, 8
F. Guestini, K. McNamara, H. Sasano (2017)
The use of chemosensitizers to enhance the response to conventional therapy in triple-negative breast cancer patientsBreast cancer management, 6
Fernando Gómez-Herreros, R. Romero-Granados, Z. Zeng, Alejandro Álvarez-Quilón, Cristina Quintero, Limei Ju, L. Umans, L. Vermeire, D. Huylebroeck, K. Caldecott, Felipe Cortés-Ledesma (2013)
TDP2–Dependent Non-Homologous End-Joining Protects against Topoisomerase II–Induced DNA Breaks and Genome Instability in Cells and In VivoPLoS Genetics, 9
Arishya Sharma, Kamini Singh, A. Almasan (2012)
Histone H2AX phosphorylation: a marker for DNA damage.Methods in molecular biology, 920
H. Interthal, Hong Chen, T. Kehl-Fie, J. Zotzmann, John Leppard, J. Champoux (2005)
SCAN1 mutant Tdp1 accumulates the enzyme–DNA intermediate and causes camptothecin hypersensitivityThe EMBO Journal, 24
H. Goto, E. Ōsawa (1993)
An efficient algorithm for searching low-energy conformers of cyclic and acyclic moleculesJournal of The Chemical Society-perkin Transactions 1
T. Khomenko, A. Zakharenko, A. Chepanova, E. Ilina, O. Zakharova, V. Kaledin, V. Nikolin, N. Popova, D. Korchagina, J. Reynisson, R. Chand, D. Ayine-Tora, Jinal Patel, Ivanhoe Leung, K. Volcho, N. Salakhutdinov, O. Lavrik (2019)
Promising New Inhibitors of Tyrosyl-DNA Phosphodiesterase I (Tdp 1) Combining 4-Arylcoumarin and Monoterpenoid Moieties as Components of Complex Antitumor TherapyInternational Journal of Molecular Sciences, 21
J. Vance, T. Wilson (2002)
Yeast Tdp1 and Rad1-Rad10 function as redundant pathways for repairing Top1 replicative damageProceedings of the National Academy of Sciences of the United States of America, 99
Jeffrey Pouliot, Kevin Yao, C. Robertson, H. Nash (1999)
Yeast gene for a Tyr-DNA phosphodiesterase that repairs topoisomerase I complexes.Science, 286 5439
E. Gladkova, I. Nechepurenko, R. Bredikhin, A. Chepanova, A. Zakharenko, O. Luzina, E. Ilina, N. Dyrkheeva, E. Mamontova, R. Anarbaev, J. Reynisson, K. Volcho, N. Salakhutdinov, O. Lavrik (2020)
The First Berberine-Based Inhibitors of Tyrosyl-DNA Phosphodiesterase 1 (Tdp1), an Important DNA Repair EnzymeInternational Journal of Molecular Sciences, 21
A. Zafar, Suat Sarı, E. Leung, L. Pilkington, M. Rensburg, D. Barker, J. Reynisson (2017)
GPCR Modulation of Thieno[2,3-b]pyridine Anti-Proliferative AgentsMolecules : A Journal of Synthetic Chemistry and Natural Product Chemistry, 22
J. Heo, Jing Li, Matthew Summerlin, Annette Hays, S. Katyal, P. Mckinnon, K. Nitiss, J. Nitiss, L. Hanakahi (2015)
TDP1 promotes assembly of non-homologous end joining protein complexes on DNA.DNA repair, 30
Alun Bermingham, E. Price, C. Marchand, Y. Pommier, K. Goncharova, Jason Evans, J. McMahon, B. O’Keefe (2009)
Abstract A174: High‐throughput screening for natural product inhibitors of human tyrosyl‐DNA‐phosphodiesterase (Tdp‐1)Molecular Cancer Therapeutics, 8
Subhendu Das, Ishita Rehman, Arijit Ghosh, Souvik Sengupta, Papiya Majumdar, B. Jana, B. Das (2016)
Poly(ADP-ribose) polymers regulate DNA topoisomerase I (Top1) nuclear dynamics and camptothecin sensitivity in living cellsNucleic Acids Research, 44
(2016)
corrr: Correlations in R. R package version 02.1
(2000)
Mechanism of action of camptothecinAnn N Y Acad Sci, 922
J. Nickoloff, Dennie Jones, Suk-hee Lee, E. Williamson, R. Hromas (2017)
Drugging the Cancers Addicted to DNA RepairJNCI Journal of the National Cancer Institute, 109
E. Martino, S. Volpe, E. Terribile, E. Benetti, M. Sakaj, Adriana Centamore, Andrea Sala, S. Collina (2017)
The long story of camptothecin: From traditional medicine to drugs.Bioorganic & medicinal chemistry letters, 27 4
Jing Li, Matthew Summerlin, K. Nitiss, J. Nitiss, L. Hanakahi (2017)
TDP1 is required for efficient non-homologous end joining in human cells.DNA repair, 60
V. Venditto, E. Simanek (2010)
Cancer therapies utilizing the camptothecins: a review of the in vivo literature.Molecular pharmaceutics, 7 2
P. Evans, G. Murshudov (2013)
How good are my data and what is the resolution?Acta Crystallographica Section D: Biological Crystallography, 69
G. Beretta, L. Gatti, P. Perego, N. Zaffaroni (2013)
Camptothecin resistance in cancer: insights into the molecular mechanisms of a DNA-damaging drug.Current medicinal chemistry, 20 12
Meryem Alagoz, Duncan Gilbert, Sherif El-khamisy, A. Chalmers (2012)
DNA repair and resistance to topoisomerase I inhibitors: mechanisms, biomarkers and therapeutic targets.Current medicinal chemistry, 19 23
R. Hertzberg, M. Caranfa, S. Hecht (1989)
On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex.Biochemistry, 28 11
C. Tesauro, A. Simonsen, M. Andersen, K. Petersen, E. Kristoffersen, Line Algreen, N. Hansen, Anne Andersen, Ann-Katrine Jakobsen, M. Stougaard, Pavel Gromov, B. Knudsen, I. Gromova (2019)
Topoisomerase I activity and sensitivity to camptothecin in breast cancer-derived cells: a comparative studyBMC Cancer, 19
H. Barthelmes, M. Habermeyer, Morten Christensen, C. Mielke, H. Interthal, Jeffrey Pouliot, F. Boege, D. Marko (2004)
TDP1 Overexpression in Human Cells Counteracts DNA Damage Mediated by Topoisomerases I and II*Journal of Biological Chemistry, 279
A. Zakharenko, O. Luzina, D. Sokolov, V. Kaledin, V. Nikolin, N. Popova, N. Popova, Jinal Patel, O. Zakharova, A. Chepanova, A. Zafar, J. Reynisson, E. Leung, Ivanhoe Leung, K. Volcho, K. Volcho, N. Salakhutdinov, N. Salakhutdinov, O. Lavrik, O. Lavrik (2019)
Novel tyrosyl-DNA phosphodiesterase 1 inhibitors enhance the therapeutic impact of topoteсan on in vivo tumor models.European journal of medicinal chemistry, 161
Z. Zeng, Felipe Cortés-Ledesma, Sherif Khamisy, K. Caldecott (2010)
TDP2/TTRAP Is the Major 5′-Tyrosyl DNA Phosphodiesterase Activity in Vertebrate Cells and Is Critical for Cellular Resistance to Topoisomerase II-induced DNA DamageThe Journal of Biological Chemistry, 286
F. Ran, P. Hsu, Jason Wright, Vineeta Agarwala, Vineeta Agarwala, David Scott, Feng Zhang (2013)
Genome engineering using the CRISPR-Cas9 systemNature Protocols, 8
O. Salomatina, I. Popadyuk, A. Zakharenko, O. Zakharova, D. Fadeev, N. Komarova, J. Reynisson, H. Arabshahi, R. Chand, K. Volcho, N. Salakhutdinov, O. Lavrik (2018)
Novel Semisynthetic Derivatives of Bile Acids as Effective Tyrosyl-DNA Phosphodiesterase 1 InhibitorsMolecules : A Journal of Synthetic Chemistry and Natural Product Chemistry, 23
Hok Fam, Cheryl Walton, Sheetal Mitra, M. Chowdhury, Nichola Osborne, K. Choi, Guobin Sun, P. Wong, M. O'sullivan, G. Turashvili, S. Aparicio, T. Triche, M. Bond, C. Pallen, C. Boerkoel (2013)
TDP1 and PARP1 Deficiency Are Cytotoxic to Rhabdomyosarcoma CellsMolecular Cancer Research, 11
H. Arabshahi, M. Rensburg, L. Pilkington, Chae Jeon, Mirae Song, Ling Gridel, E. Leung, D. Barker, Milena Vuica-Ross, K. Volcho, A. Zakharenko, O. Lavrik, J. Reynisson (2015)
A synthesis, in silico, in vitro and in vivo study of thieno[2,3-b]pyridine anticancer analoguesMedChemComm, 6
(2011)
REFMAC5 for the refinement of macromolecular crystal structuresActa Crystallogr D Biol Crystallogr, 67
S. Parasuraman (2012)
Protein data bankJournal of Pharmacology & Pharmacotherapeutics, 3
E. Mozhaitsev, A. Zakharenko, E. Suslov, D. Korchagina, O. Zakharova, I. Vasil’eva, A. Chepanova, Ellena Black, Jinal Patel, R. Chand, J. Reynisson, Ivanhoe Leung, K. Volcho, N. Salakhutdinov, O. Lavrik (2019)
Novel Inhibitors of DNA Repair Enzyme TDP1 Combining Monoterpenoid and Adamantane Fragments.Anti-cancer agents in medicinal chemistry
J. Reynisson, J. Jaiswal, D. Barker, Stacey D’mello, W. Denny, B. Baguley, E. Leung (2016)
Evidence that phospholipase C is involved in the antitumour action of NSC768313, a new thieno[2,3-b]pyridine derivativeCancer Cell International, 16
I. Il’ina, N. Dyrkheeva, A. Zakharenko, A. Sidorenko, N. Li-Zhulanov, D. Korchagina, R. Chand, D. Ayine-Tora, A. Chepanova, O. Zakharova, E. Ilina, J. Reynisson, A. Malakhova, S. Medvedev, S. Zakian, K. Volcho, N. Salakhutdinov, O. Lavrik (2020)
Design, Synthesis, and Biological Investigation of Novel Classes of 3-Carene-Derived Potent Inhibitors of TDP1Molecules, 25
(2004)
Coot: model-building tools for molecular graphics
HM Berman (2000)
235Nucleic Acids Res, 28
W. Mooij, M. Verdonk (2005)
General and targeted statistical potentials for protein–ligand interactionsProteins: Structure, 61
G. Capranico, Jessica Marinello, G. Chillemi (2017)
Type I DNA Topoisomerases.Journal of medicinal chemistry, 60 6
G. Lountos, X. Zhao, E. Kiselev, J. Tropea, D. Needle, Y. Pommier, T. Burke, D. Waugh (2019)
Identification of a ligand binding hot spot and structural motifs replicating aspects of tyrosyl-DNA phosphodiesterase I (TDP1) phosphoryl recognition by crystallographic fragment cocktail screening.Nucleic acids research
K. Ponomarev, E. Suslov, A. Zakharenko, O. Zakharova, A. Rogachev, D. Korchagina, A. Zafar, J. Reynisson, A. Nefedov, K. Volcho, N. Salakhutdinov, O. Lavrik (2018)
Aminoadamantanes containing monoterpene-derived fragments as potent tyrosyl-DNA phosphodiesterase 1 inhibitors.Bioorganic chemistry, 76
C. Deng, James Brown, Dongqing You, J. Brown (2005)
Multiple Endonucleases Function to Repair Covalent Topoisomerase I Complexes in Saccharomyces cerevisiaeGenetics, 170
M. Verdonk, J. Cole, M. Hartshorn, C. Murray, Richard Taylor (2003)
Improved protein–ligand docking using GOLDProteins: Structure, 52
M. Gilski, Maciej Kazmierczyk, S. Krzywda, Helena Zábranská, S. Cooper, Zoran Popović, Firas Khatib, F. DiMaio, James Thompson, D. Baker, Iva Pichovác, Mariusz Jaskolskia (2011)
High-resolution structure of a retroviral protease folded as a monomer
A. Chepanova, N. Li-Zhulanov, A. Sukhikh, A. Zafar, J. Reynisson, A. Zakharenko, O. Zakharova, D. Korchagina, K. Volcho, N. Salakhutdinov, O. Lavrik (2019)
Effective Inhibitors of Tyrosyl-DNA Phosphodiesterase 1 Based on Monoterpenoids as Potential Agents for Antitumor TherapyRussian Journal of Bioorganic Chemistry, 45
C. Meisenberg, D. Gilbert, A. Chalmers, V. Haley, S. Gollins, S. Ward, Sherif El-khamisy (2014)
Clinical and Cellular Roles for TDP1 and TOP1 in Modulating Colorectal Cancer Response to IrinotecanMolecular Cancer Therapeutics, 14
O. Zakharova, O. Luzina, A. Zakharenko, D. Sokolov, A. Filimonov, N. Dyrkheeva, A. Chepanova, E. Ilina, A. Ilyina, K. Klabenkova, B. Chelobanov, D. Stetsenko, A. Zafar, Chatchakorn Eurtivong, J. Reynisson, K. Volcho, N. Salakhutdinov, O. Lavrik (2018)
Synthesis and evaluation of aryliden- and hetarylidenfuranone derivatives of usnic acid as highly potent Tdp1 inhibitors.Bioorganic & medicinal chemistry, 26 15
Stefanie Chen, N. Chan, T. Hsieh (2013)
New mechanistic and functional insights into DNA topoisomerases.Annual review of biochemistry, 82
N. Allinger (1977)
Conformational analysis. 130. MM2. A hydrocarbon force field utilizing V1 and V2 torsional termsJournal of the American Chemical Society, 99
A. Mccoy, R. Grosse-Kunstleve, P. Adams, M. Winn, L. Storoni, R. Read (2007)
Phaser crystallographic softwareJournal of Applied Crystallography, 40
Aleksander Filimonov, A. Chepanova, O. Luzina, A. Zakharenko, O. Zakharova, E. Ilina, N. Dyrkheeva, M. Kuprushkin, A. Kolotaev, D. Khachatryan, Jinal Patel, Ivanhoe Leung, R. Chand, D. Ayine-Tora, J. Reynisson, K. Volcho, N. Salakhutdinov, O. Lavrik (2019)
New Hydrazinothiazole Derivatives of Usnic Acid as Potent Tdp1 InhibitorsMolecules, 24
O. Korb, T. Stützle, T. Exner (2009)
Empirical Scoring Functions for Advanced Protein-Ligand Docking with PLANTSJournal of chemical information and modeling, 49 1
Craig Thomas, Nicolas Rahier, S. Hecht (2004)
Camptothecin: current perspectives.Bioorganic & medicinal chemistry, 12 7
G. Jones, P. Willett, R. Glen, Andrew Leach, Robin Taylor (1997)
Development and validation of a genetic algorithm for flexible docking.Journal of molecular biology, 267 3
T. McPhillips, S. Mcphillips, H. Chiu, A. Cohen, A. Deacon, Paul Ellis, E. Garman, Ana González, N. Sauter, R. Phizackerley, S. Soltis, P. Kuhn (2002)
Blu-Ice and the Distributed Control System: software for data acquisition and instrument control at macromolecular crystallography beamlines.Journal of synchrotron radiation, 9 Pt 6
(2017)
Drugging the cancers addicted to DNA repairJ Natl Cancer Inst, 109
T. Khomenko, A. Zakharenko, Tatyana Odarchenko, H. Arabshahi, V. Sannikova, O. Zakharova, D. Korchagina, J. Reynisson, K. Volcho, N. Salakhutdinov, O. Lavrik (2016)
New inhibitors of tyrosyl-DNA phosphodiesterase I (Tdp 1) combining 7-hydroxycoumarin and monoterpenoid moieties.Bioorganic & medicinal chemistry, 24 21
E. Mamontova, A. Zakharenko, O. Zakharova, N. Dyrkheeva, K. Volcho, J. Reynisson, H. Arabshahi, N. Salakhutdinov, O. Lavrik (2019)
Identification of novel inhibitors for the tyrosyl-DNA-phosphodiesterase 1 (Tdp1) mutant SCAN1 using virtual screening.Bioorganic & medicinal chemistry
H. Interthal, Jeffrey Pouliot, J. Champoux (2001)
The tyrosyl-DNA phosphodiesterase Tdp1 is a member of the phospholipase D superfamilyProceedings of the National Academy of Sciences of the United States of America, 98
A. Chepanova, E. Mozhaitsev, A. Munkuev, E. Suslov, D. Korchagina, O. Zakharova, A. Zakharenko, Jinal Patel, D. Ayine-Tora, J. Reynisson, Ivanhoe Leung, K. Volcho, N. Salakhutdinov, O. Lavrik (2019)
The Development of Tyrosyl-DNA Phosphodiesterase 1 Inhibitors. Combination of Monoterpene and Adamantine Moieties via Amide or Thioamide BridgesApplied Sciences
Naif Binsaleh, Catherine Wigley, K. Whitehead, M. Rensburg, J. Reynisson, L. Pilkington, D. Barker, S. Jones, N. Dempsey-Hibbert (2018)
Thieno[2,3-b]pyridine derivatives are potent anti-platelet drugs, inhibiting platelet activation, aggregation and showing synergy with aspirin.European journal of medicinal chemistry, 143
Cancer chemotherapy sensitizers hold the key to maximizing the potential of standard anticancer treatments. We have a long-standing interest in developing and validating inhibitors of the DNA repair enzyme tyrosyl-DNA phosphodiesterase 1 (TDP1) as chemosensitizers for topoisomerase I poisons such as topotecan. Herein, by using thieno[2,3-b]pyridines, a class of TDP1 inhibitors, we showed that the inhibition of TDP1 can restore sensitivity to topotecan, results that are supported by TDP1 knockout cell experiments using CRISPR/Cas9. However, we also found that the restored sensitivity towards topoisomerase I inhibitors is likely regulated by multiple complementary DNA repair pathways. Our results showed that one of these pathways is likely modulated by PARP1, although it is also possible that other redundant and partially overlapping pathways may be involved in the DNA repair process. Our work thus raises the prospect of targeting multiple DNA repair pathways to increase the sensitivity to topoisomerase I inhibitors.
Oncology and Therapy – Springer Journals
Published: Dec 1, 2021
Keywords: DNA repair; TDP1; Thieno[2,3-b]pyridines; Topotecan; Topoisomerase I
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.